{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:09:46Z","timestamp":1784830186868,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017220","name":"Regional Centre for Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijbiomac.2020.12.038","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T15:48:18Z","timestamp":1607528898000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs"],"prefix":"10.1016","volume":"168","author":[{"given":"Naveen","family":"Narayanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak T.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0005","unstructured":"Johns Hopkins Coronavirus Resource Center, (n.d.)."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0010","series-title":"Covid-19: a brief overview of the discovery clinical trial, Pharmaceuticals","author":"Vanden Eynde","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0015","series-title":"A new coronavirus associated with human respiratory disease in China, Nature","author":"Wu","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41541-020-0170-0","article-title":"The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines","volume":"5","author":"Shang","year":"2020","journal-title":"Npj Vaccines."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-020-01402-1","article-title":"Characterization of accessory genes in coronavirus genomes","volume":"17","author":"Michel","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virusres.2007.02.017","article-title":"SARS coronavirus replicase proteins in pathogenesis","volume":"133","author":"Graham","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0035","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.str.2005.07.022","article-title":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1\u2033-phosphate dephosphorylation by a conserved domain of nsP3","volume":"13","author":"Saikatendu","year":"2005","journal-title":"Structure."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0040","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0045","doi-asserted-by":"crossref","unstructured":"A.R. Fehr, S. Perlman, Coronaviruses: an overview of their replication and pathogenesis, in: Coronaviruses Methods Protoc., Springer New York, 2015: pp. 1\u201323. doi:https:\/\/doi.org\/10.1007\/978-1-4939-2438-7_1.","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex","author":"Ma","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0055","doi-asserted-by":"crossref","unstructured":"G.M. Yin W, Mao C, Luan X, Shen DD, Shen Q, Su H, Wang X, Zhou F, Zhao W, Z. Chang S, Xie YC, Tian G, Jiang HW, Tao SC, Shen J, Jiang Y, Jiang H, Xu Y, X.H. S, Zhang Y, Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir, Science (80-.). (2020). doi:https:\/\/doi.org\/10.1101\/2020.02.07.937862.","DOI":"10.1101\/2020.04.08.032763"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0065","doi-asserted-by":"crossref","unstructured":"W. Yin, C. Mao, X. Luan, D.-D. Shen, Q. Shen, H. Su, X. Wang, F. Zhou, W. Zhao, M. Gao, S. Chang, Y.-C. Xie, G. Tian, H.-W. Jiang, S.-C. Tao, J. Shen, Y. Jiang, H. Jiang, Y. Xu, S. Zhang, Y. Zhang, H.E. Xu, Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir, Science (80-.). (2020) eabc1560. doi:https:\/\/doi.org\/10.1126\/science.abc1560.","DOI":"10.1101\/2020.04.08.032763"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0070","doi-asserted-by":"crossref","unstructured":"Q. Wang, J. Wu, H. Wang, Y. Gao, Q. Liu, A. Mu, W. Ji, L. Yan, Y. Zhu, C. Zhu, X. Fang, X. Yang, Y. Huang, H. Gao, F. Liu, J. Ge, Q. Sun, X. Yang, W. Xu, Z. Liu, H. Yang, Z. Lou, B. Jiang, L.W. Guddat, P. Gong, Z. Rao, Structural basis for RNA replication by the SARS-CoV-2 polymerase, Cell. 182 (2020) 417\u2013428.e13. doi:https:\/\/doi.org\/10.1016\/j.cell.2020.05.034.","DOI":"10.1016\/j.cell.2020.05.034"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0080","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1038\/s41467-020-19770-1","article-title":"Architecture of a SARS-CoV-2 mini replication and transcription complex","volume":"11","author":"Yan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0085","doi-asserted-by":"crossref","unstructured":"J. Chen, B. Malone, E. Llewellyn, M. Grasso, P.M.M. Shelton, P.D.B. Olinares, K. Maruthi, E.T. Eng, H. Vatandaslar, B.T. Chait, T.M. Kapoor, S.A. Darst, E.A. Campbell, Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex, Cell. 182 (2020) 1560\u20131573.e13. doi:https:\/\/doi.org\/10.1016\/j.cell.2020.07.033.","DOI":"10.1016\/j.cell.2020.07.033"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0090","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/pro.3873","article-title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2","volume":"29","author":"Kim","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0095","doi-asserted-by":"crossref","unstructured":"P. Krafcikova, J. Silhan, R. Nencka, E. Boura, Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin, Nat. Commun. 11 (2020). doi:https:\/\/doi.org\/10.1038\/s41467-020-17495-9.","DOI":"10.1038\/s41467-020-17495-9"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0100","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0105","doi-asserted-by":"crossref","first-page":"W351","DOI":"10.1093\/nar\/gkw357","article-title":"Dali server update","volume":"44","author":"Holm","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0110","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M700039200","article-title":"The crystal structure of TREX1 explains the 3\u2032 nucleotide specificity and reveals a polyproline II helix for protein partnering","author":"De Silva","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0115","doi-asserted-by":"crossref","unstructured":"K.J. Bowers, E. Chow, H. Xu, R.O. Dror, M.P. Eastwood, B.A. Gregersen, J.L. Klepeis, I. Kolossvary, M.A. Moraes, F.D. Sacerdoti, J.K. Salmon, Y. Shan, D.E. Shaw, Scalable algorithms for molecular dynamics simulations on commodity clusters, in: Proc. 2006 ACM\/IEEE Conf. Supercomput. SC'06, ACM Press, New York, New York, USA, 2006: p. 84. doi:https:\/\/doi.org\/10.1145\/1188455.1188544.","DOI":"10.1145\/1188455.1188544"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New method for fast and accurate binding-site identification and analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0130","unstructured":"Selleckchem.com - Inhibitor Expert (Inhibitors, Compound Libraries), (n.d.)."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0135","doi-asserted-by":"crossref","unstructured":"R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.H. Knoll, M. Shelley, J.K. Perry, D.E. Shaw, P. Francis, P.S. Shenkin, Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem. 47 (2004) 1739\u20131749. doi:https:\/\/doi.org\/10.1021\/jm0306430.","DOI":"10.1021\/jm0306430"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0145","doi-asserted-by":"crossref","unstructured":"J. Li, R. Abel, K. Zhu, Y. Cao, S. Zhao, R.A. Friesner, The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling, Proteins Struct. Funct. Bioinforma. 79 (2011) 2794\u20132812. doi:https:\/\/doi.org\/10.1002\/prot.23106.","DOI":"10.1002\/prot.23106"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/prot.21715","article-title":"QMEAN: a comprehensive scoring function for model quality assessment","author":"Benkert","year":"2008","journal-title":"Proteins Struct. Funct. Genet."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0155","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cellsig.2016.02.010","article-title":"The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias","volume":"28","author":"Welihinda","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2019.04.006","article-title":"Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation","volume":"302","author":"Park","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0165","unstructured":"Ritonavir - DrugBank, (n.d.)."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0175","doi-asserted-by":"crossref","unstructured":"B. Cao, Y. Wang, D. Wen, W. Liu, J. Wang, G. Fan, L. Ruan, B. Song, Y. Cai, M. Wei, X. Li, J. Xia, N. Chen, J. Xiang, T. Yu, T. Bai, X. Xie, L. Zhang, C. Li, Y. Yuan, H. Chen, H. Li, H. Huang, S. Tu, F. Gong, Y. Liu, Y. Wei, C. Dong, F. Zhou, X. Gu, J. Xu, Z. Liu, Y. Zhang, H. Li, L. Shang, K. Wang, K. Li, X. Zhou, X. Dong, Z. Qu, S. Lu, X. Hu, S. Ruan, S. Luo, J. Wu, L. Peng, F. Cheng, L. Pan, J. Zou, C. Jia, J. Wang, X. Liu, S. Wang, X. Wu, Q. Ge, J. He, H. Zhan, F. Qiu, L. Guo, C. Huang, T. Jaki, F.G. Hayden, P.W. Horby, D. Zhang, C. Wang, A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19, N. Engl. J. Med. (2020). doi:https:\/\/doi.org\/10.1056\/NEJMoa2001282.","DOI":"10.1056\/NEJMoa2001282"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0180","series-title":"Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy, Heredity (Edinb)","author":"Jensen","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0185","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01624-06","article-title":"Theory of lethal mutagenesis for viruses","author":"Bull","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0190","article-title":"Murine hepatitis virus nsp14 exoribonuclease activity is required for resistance to innate immunity","author":"Case","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0195","series-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease, MBio","author":"Agostini","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0200","article-title":"Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA","author":"Ferron","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0210","doi-asserted-by":"crossref","unstructured":"T.K. Warren, R. Jordan, M.K. Lo, A.S. Ray, R.L. Mackman, V. Soloveva, D. Siegel, M. Perron, R. Bannister, H.C. Hui, N. Larson, R. Strickley, J. Wells, K.S. Stuthman, S.A. Van Tongeren, N.L. Garza, G. Donnelly, A.C. Shurtleff, C.J. Retterer, D. Gharaibeh, R. Zamani, T. Kenny, B.P. Eaton, E. Grimes, L.S. Welch, L. Gomba, C.L. Wilhelmsen, D.K. Nichols, J.E. Nuss, E.R. Nagle, J.R. Kugelman, G. Palacios, E. Doerffler, S. Neville, E. Carra, M.O. Clarke, L. Zhang, W. Lew, B. Ross, Q. Wang, K. Chun, L. Wolfe, D. Babusis, Y. Park, K.M. Stray, I. Trancheva, J.Y. Feng, O. Barauskas, Y. Xu, P. Wong, M.R. Braun, M. Flint, L.K. McMullan, S.S. Chen, R. Fearns, S. Swaminathan, D.L. Mayers, C.F. Spiropoulou, W.A. Lee, S.T. Nichol, T. Cihlar, S. Bavari, Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys, Nature. (2016). doi:https:\/\/doi.org\/10.1038\/nature17180.","DOI":"10.1038\/nature17180"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0215","article-title":"The antiviral compound remdesivir potently inhibits RNAdependent RNA polymerase from Middle East respiratory syndrome coronavirus","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0225","doi-asserted-by":"crossref","unstructured":"E.P. Tchesnokov, J.Y. Feng, D.P. Porter, M. G\u00f6tte, Mechanism of inhibition of ebola virus RNA-dependent RNA polymerase by remdesivir, Viruses. 11 (2019). doi:https:\/\/doi.org\/10.3390\/v11040326.","DOI":"10.3390\/v11040326"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0230","doi-asserted-by":"crossref","unstructured":"G.M. Yin W, Mao C, Luan X, Shen DD, Shen Q, Su H, Wang X, Zhou F, Zhao W, Z. Chang S, Xie YC, Tian G, Jiang HW, Tao SC, Shen J, Jiang Y, Jiang H, Xu Y, X.H. S, Zhang Y, Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir, Science (80-.). (2020). doi:https:\/\/doi.org\/10.1101\/2020.02.07.937862.","DOI":"10.1101\/2020.04.08.032763"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0235","series-title":"Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites, Antiviral Res","author":"Shannon","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0240","article-title":"Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19","volume":"1","author":"Selvaraj","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0245","doi-asserted-by":"crossref","unstructured":"Lopinavir\/ritonavir, ribavirin and IFN-beta combination for nCoV treatment, Case Med. Res. (2020). doi:10.31525\/ct1-nct04276688.","DOI":"10.31525\/ct1-nct04276688"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0250","doi-asserted-by":"crossref","unstructured":"I.F.-N. Hung, K.-C. Lung, E.Y.-K. Tso, R. Liu, T.W.-H. Chung, M.-Y. Chu, Y.-Y. Ng, J. Lo, J. Chan, A.R. Tam, H.-P. Shum, V. Chan, A.K.-L. Wu, K.-M. Sin, W.-S. Leung, W.-L. Law, D.C. Lung, S. Sin, P. Yeung, C.C.-Y. Yip, R.R. Zhang, A.Y.-F. Fung, E.Y.-W. Yan, K.-H. Leung, J.D. Ip, A.W.-H. Chu, W.-M. Chan, A.C.-K. Ng, R. Lee, K. Fung, A. Yeung, T.-C. Wu, J.W.-M. Chan, W.-W. Yan, W.-M. Chan, J.F.-W. Chan, A.K.-W. Lie, O.T.-Y. Tsang, V.C.-C. Cheng, T.-L. Que, C.-S. Lau, K.-H. Chan, K.K.-W. To, K.-Y. Yuen, Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, Lancet. (2020). doi:https:\/\/doi.org\/10.1016\/S0140-6736(20)31042-4.","DOI":"10.1016\/S0140-6736(20)31042-4"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0255","series-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax","author":"Chu","year":"2004"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0260","doi-asserted-by":"crossref","unstructured":"J. Grein, N. Ohmagari, D. Shin, G. Diaz, E. Asperges, A. Castagna, T. Feldt, G. Green, M.L. Green, F.-X. Lescure, E. Nicastri, R. Oda, K. Yo, E. Quiros-Roldan, A. Studemeister, J. Redinski, S. Ahmed, J. Bernett, D. Chelliah, D. Chen, S. Chihara, S.H. Cohen, J. Cunningham, A. D'Arminio Monforte, S. Ismail, H. Kato, G. Lapadula, E. L'Her, T. Maeno, S. Majumder, M. Massari, M. Mora-Rillo, Y. Mutoh, D. Nguyen, E. Verweij, A. Zoufaly, A.O. Osinusi, A. DeZure, Y. Zhao, L. Zhong, A. Chokkalingam, E. Elboudwarej, L. Telep, L. Timbs, I. Henne, S. Sellers, H. Cao, S.K. Tan, L. Winterbourne, P. Desai, R. Mera, A. Gaggar, R.P. Myers, D.M. Brainard, R. Childs, T. Flanigan, Compassionate use of remdesivir for patients with severe Covid-19, N. Engl. J. Med. (2020). doi:https:\/\/doi.org\/10.1056\/nejmoa2007016.","DOI":"10.1056\/NEJMoa2007016"},{"key":"10.1016\/j.ijbiomac.2020.12.038_bb0265","first-page":"1","article-title":"Liver injury in remdesivir-treated COVID-19 patients","volume":"1","author":"Zampino","year":"2020","journal-title":"Hepatol. Int."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020351977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020351977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:23:40Z","timestamp":1758875020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020351977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":53,"alternative-id":["S0141813020351977"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.038","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv.12280043.v1","asserted-by":"object"},{"id-type":"doi","id":"10.26434\/chemrxiv.12280043","asserted-by":"object"}]},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}